Latest Insider Transactions at Homology Medicines, Inc. (FIXX)
This section provides a real-time view of insider transactions for Homology Medicines, Inc. (FIXX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Homology Medicines, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Homology Medicines, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2024
|
Shelia M. Violette Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+20.08%
|
$42,000
$7.29 P/Share
|
|
Oct 11
2024
|
Shelia M. Violette Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,574
+20.38%
|
$13,722
$3.12 P/Share
|
|
Oct 08
2024
|
Shelia M. Violette Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,300
+50.0%
|
$39,900
$3.12 P/Share
|
|
Mar 25
2024
|
Arthur Tzianabos |
SELL
Open market or private sale
|
Direct |
265
-3.21%
|
$6,360
$24.2 P/Share
|
|
Mar 25
2024
|
Arthur Tzianabos |
BUY
Exercise of conversion of derivative security
|
Direct |
1,095
+11.72%
|
-
|
|
Mar 25
2024
|
Charles Michaud Jr |
SELL
Open market or private sale
|
Direct |
75
-7.49%
|
$1,800
$24.2 P/Share
|
|
Mar 25
2024
|
Paul Alloway |
SELL
Open market or private sale
|
Direct |
268
-9.36%
|
$6,432
$24.21 P/Share
|
|
Mar 25
2024
|
Charles Michaud Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
6,448
+26.32%
|
-
|
|
Mar 25
2024
|
Paul Alloway |
BUY
Exercise of conversion of derivative security
|
Direct |
23,530
+31.33%
|
-
|
|
Jan 09
2024
|
Arthur Tzianabos |
SELL
Open market or private sale
|
Direct |
13,037
-9.19%
|
$0
$0.57 P/Share
|
|
Jan 03
2024
|
Paul Alloway |
SELL
Open market or private sale
|
Direct |
7,280
-20.61%
|
$0
$0.57 P/Share
|
|
Jan 03
2024
|
Charles Michaud Jr |
SELL
Open market or private sale
|
Direct |
1,708
-12.84%
|
$0
$0.57 P/Share
|
|
Jan 01
2024
|
Arthur Tzianabos |
BUY
Exercise of conversion of derivative security
|
Direct |
33,420
+11.16%
|
-
|
|
Jan 01
2024
|
Charles Michaud Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
4,240
+10.31%
|
-
|
|
Jan 01
2024
|
Paul Alloway |
BUY
Exercise of conversion of derivative security
|
Direct |
18,610
+18.04%
|
-
|
|
Sep 06
2023
|
Albert Seymour |
SELL
Open market or private sale
|
Direct |
1,448
-0.95%
|
$1,448
$1.15 P/Share
|
|
Sep 06
2023
|
Albert Seymour |
BUY
Exercise of conversion of derivative security
|
Direct |
4,620
+2.94%
|
-
|
|
Aug 03
2023
|
Julie Jordan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,853
-9.17%
|
$1,853
$1.39 P/Share
|
|
Aug 03
2023
|
Julie Jordan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,579
+23.08%
|
-
|
|
Aug 02
2023
|
Julie Jordan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
99
-3.45%
|
$99
$1.31 P/Share
|
|
Aug 02
2023
|
Julie Jordan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
350
+10.87%
|
-
|
|
Mar 02
2023
|
Paul Alloway |
SELL
Open market or private sale
|
Direct |
10,965
-39.63%
|
$10,965
$1.45 P/Share
|
|
Jan 09
2023
|
Arthur Tzianabos |
SELL
Open market or private sale
|
Direct |
10,616
-8.92%
|
$10,616
$1.39 P/Share
|
|
Jan 09
2023
|
Albert Seymour |
SELL
Open market or private sale
|
Direct |
3,620
-2.47%
|
$3,620
$1.39 P/Share
|
|
Jan 09
2023
|
W Bradford Smith Officer |
SELL
Open market or private sale
|
Direct |
3,729
-20.78%
|
$3,729
$1.39 P/Share
|
|
Jan 09
2023
|
Paul Alloway |
SELL
Open market or private sale
|
Direct |
3,090
-13.32%
|
$3,090
$1.39 P/Share
|
|
Jan 09
2023
|
Michael Lee Blum Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,454
-15.35%
|
$2,454
$1.39 P/Share
|
|
Jan 01
2023
|
Paul Alloway |
BUY
Exercise of conversion of derivative security
|
Direct |
9,570
+18.93%
|
-
|
|
Jan 01
2023
|
W Bradford Smith Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,530
+32.66%
|
-
|
|
Jan 01
2023
|
Albert Seymour |
BUY
Exercise of conversion of derivative security
|
Direct |
11,220
+3.74%
|
-
|
|
Jan 01
2023
|
Arthur Tzianabos |
BUY
Exercise of conversion of derivative security
|
Direct |
33,000
+13.02%
|
-
|
|
Jan 01
2023
|
Michael Lee Blum Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,590
+21.47%
|
-
|
|
Jan 05
2022
|
Arthur Tzianabos |
SELL
Open market or private sale
|
Direct |
5,354
-5.86%
|
$16,062
$3.78 P/Share
|
|
Jan 05
2022
|
Gabriel Cohn Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,661
-38.72%
|
$4,983
$3.78 P/Share
|
|
Jan 05
2022
|
Albert Seymour |
SELL
Open market or private sale
|
Direct |
1,661
-1.25%
|
$4,983
$3.78 P/Share
|
|
Jan 05
2022
|
Timothy P Kelly Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,406
-38.73%
|
$4,218
$3.78 P/Share
|
|
Jan 05
2022
|
W Bradford Smith Officer |
SELL
Open market or private sale
|
Direct |
2,182
-33.06%
|
$6,546
$3.78 P/Share
|
|
Jan 01
2022
|
Arthur Tzianabos |
BUY
Exercise of conversion of derivative security
|
Direct |
13,860
+13.17%
|
-
|
|
Jan 01
2022
|
Gabriel Cohn Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,290
+50.0%
|
-
|
|
Jan 01
2022
|
Albert Seymour |
BUY
Exercise of conversion of derivative security
|
Direct |
4,290
+3.12%
|
-
|
|
Jan 01
2022
|
Timothy P Kelly Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,630
+50.0%
|
-
|
|
Jan 01
2022
|
W Bradford Smith Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+50.0%
|
-
|
|
Sep 03
2021
|
Timothy P Kelly Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
54
-100.0%
|
$378
$7.7 P/Share
|
|
Mar 01
2021
|
Timothy P Kelly Chief Operating Officer |
BUY
Open market or private sale
|
Direct |
6,232
+100.0%
|
$68,552
$11.16 P/Share
|
|
Mar 01
2021
|
Timothy P Kelly Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+28.19%
|
$16,000
$4.76 P/Share
|
|
Feb 08
2021
|
W Bradford Smith Officer |
SELL
Open market or private sale
|
Direct |
13,500
-100.0%
|
$189,000
$14.25 P/Share
|
|
Feb 08
2021
|
W Bradford Smith Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+50.0%
|
$0
$0.64 P/Share
|
|
Feb 02
2021
|
Timothy P Kelly Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
500
-100.0%
|
$6,500
$13.0 P/Share
|
|
Feb 02
2021
|
Timothy P Kelly Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$3,000
$6.63 P/Share
|
|
Feb 01
2021
|
Timothy P Kelly Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$48,000
$12.37 P/Share
|